Page last updated: 2024-08-21

osthol and Fatty Liver

osthol has been researched along with Fatty Liver in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Hu, J; Li, X; Mo, Y; Qiu, Z; Rao, H; Tian, X; Wu, D; Wu, Y; Zheng, G1
Hu, S; Huang, CH; Huang, SC; Huang, WC; Liao, PC; Wu, SJ1
Qi, ZG; Xie, ML; Zhao, X; Zhong, W1
Wang, F; Xie, M; Zhao, X; Zhou, R; Zhu, Z1
Qi, Z; Wang, H; Xie, M; Xue, J; Zhang, Y1
Du, R; Wang, HB; Xie, ML; Xue, J; Zhang, Y1
Gu, ZL; Song, F; Xie, ML; Xue, J; Zhang, KP; Zhu, LJ1
Gu, ZL; Xie, ML; Zhang, Y; Zhu, LJ1
Gu, Z; Xie, M; Xue, J; Zhang, Y1

Other Studies

9 other study(ies) available for osthol and Fatty Liver

ArticleYear
Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.
    European journal of pharmacology, 2020, Jan-15, Volume: 867

    Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Coumarins; Disease Models, Animal; Disease Progression; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Fatty Acid Synthase, Type I; Fatty Liver; Female; Humans; Lipogenesis; Liver; Liver Neoplasms; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors

2020
Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 91

    Topics: Adipogenesis; AMP-Activated Protein Kinases; Animals; Antioxidants; Cell Death; Cell Line; Coumarins; Cyclooxygenase 2; Fatty Acid Synthases; Fatty Liver; Gene Expression Regulation; Hepatocytes; Hydrogen Peroxide; Inflammation Mediators; Lipids; Lipolysis; Mice; NF-kappa B; Phosphorylation; RNA, Messenger; Transcription Factors

2017
Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats.
    Pharmaceutical biology, 2016, Volume: 54, Issue:5

    Topics: Adipose Tissue; Animals; Blood Glucose; Coumarins; Dose-Response Relationship, Drug; Fatty Liver; Gene Targeting; Glucose; Lipid Metabolism; Liver; Male; Muscle, Skeletal; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley

2016
PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats.
    Inflammopharmacology, 2018, Volume: 26, Issue:2

    Topics: Anilides; Animals; Coumarins; Fatty Acids, Nonesterified; Fatty Liver; Indoles; Inflammation; Lipid Metabolism; Liver; Male; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Triglycerides

2018
Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
    Planta medica, 2011, Volume: 77, Issue:3

    Topics: Adiponectin; Animals; Blood Glucose; Cnidium; Coumarins; Dietary Fats; Dietary Sucrose; Fatty Liver; Fenofibrate; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Insulin; Insulin Resistance; Lipids; Liver; Male; Peroxisome Proliferator-Activated Receptors; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2011
Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression.
    European journal of pharmacology, 2011, Volume: 666, Issue:1-3

    Topics: Animals; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Coumarins; Dietary Fats; Fatty Acid Synthases; Fatty Acids, Nonesterified; Fatty Liver; Gene Expression Regulation; Liver; Male; Mice; Milk; Non-alcoholic Fatty Liver Disease; Organ Size; Receptors, LDL; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Sterol Regulatory Element Binding Proteins; Triglycerides

2011
Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals.
    World journal of gastroenterology, 2006, Jul-21, Volume: 12, Issue:27

    Topics: Adjuvants, Immunologic; Animals; Cholesterol; Cholesterol, LDL; Coumarins; Fatty Liver; Fatty Liver, Alcoholic; Glutathione Peroxidase; Hyperlipidemias; Male; Malondialdehyde; Quail; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Triglycerides

2006
Therapeutic effect of osthole on hyperlipidemic fatty liver in rats.
    Acta pharmacologica Sinica, 2007, Volume: 28, Issue:3

    Topics: Animals; Antioxidants; Cnidium; Coumarins; Fatty Liver; Fenofibrate; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipids; Liver; Male; Mice; Rats; Rats, Sprague-Dawley

2007
Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression.
    Planta medica, 2007, Volume: 73, Issue:8

    Topics: Animals; Cholesterol; Cnidium; Coumarins; Dietary Fats; DNA Primers; Fatty Liver; Fruit; Gene Expression Regulation; Hypolipidemic Agents; Male; Milk; Phytotherapy; Plant Extracts; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; Triglycerides

2007